OHE Academy

Demystifying the intricacies of health economics via accessible education suitable for learners at all stages of their health economic journey. Our goal is to empower individuals with the knowledge and skills necessary to navigate the complexities of our discipline

OHE’s educational mission is to encourage and support a deeper understanding of the dynamic field of health economics, aspiring to expand the influence and impact of health economics.


Our Introductions provide a gateway to essential health economic topics. By offering an accessible entry point, these Introductions enable individuals to grasp the fundamental concepts and principles related to health economics, establishing the groundwork for a deeper exploration of OHE’s extensive research. Whether you’re delving into the intricacies of health economics or simply curious, these resources will empower you with valuable insights and knowledge.



OHE Programmes offer a structured journey from foundational principles to advanced content, ensuring participants gain a comprehensive understanding and a seamless transfer of health economic knowledge.

  • EVIA Programme

    The Economics of Vaccines and Immunisation in Africa (EVIA) – a free-to-access, fully virtual, multi-language e-learning programme.

    Enrol to start your journey

  • Exploring the U.S. Inflation Reduction Act Program

    Free on-demand Program

    Discover the technical details of the Inflation Reduction Act (IRA) and its potential impact on the US health care system and drug development landscape.

    What is the IRA? The IRA, signed into law in 2022, represents one of the largest investments in the American economy, energy security, and climate. But what does it mean for pharmaceutical payment and coverage?

    Our educational program equips learners with essential knowledge to engage in informed conversations around the IRA:

    • Drug Selection and Price Setting: Understand the process starting in 2023.
    • Inflation Rebate Provisions: Explore how these provisions affect Medicare Part B and Part D drugs.
    • Medicare Part D Benefit Redesign: Learn about cost sharing, premiums, and subsidies.

    Sign up for free today to explore the Explaining the U.S. Inflation Reduction Act Program on OHE Academy.

    This material was produced with financial support from PhRMA. The views expressed in these presentations are those of the speakers and do not necessarily reflect PhRMA’s views or positions. This material does not constitute legal advice – it represents the speakers’ best read of the Inflation Reduction Act of 2022, Public Law 117-169, and the CMS memo entitled “Medicare Drug Price Negotiation Program: Initial Memorandum, Implementation of Sections 1191-1198 [of the SSA for IPAY 2026] and Solicitation of Comments,” as of 15 March 2023.

    Sign up today

  • Collaborating on Payment Models for Multi-Indication Therapies Masterclass

    Free on-demand Masterclass

    Unlock the potential of multi-indication therapies at your own pace with our comprehensive on-demand Masterclass. Dive into the intersection of science, payment models, and patient care. Discover how individual medicines benefit patients across various indications and learn strategies for addressing access challenges. Explore discussions about innovative approaches to pricing and reimbursement that better reflect clinical benefits.

    Sign up for free today to access the Collaborating on Payment Models for Multi-Indication Therapies Masterclass on OHE Academy.

    For more details, you can access the full report on Payment Models for Multi-Indication Therapies by Amanda Cole, Margherita Neri, and Graham Cookson, commissioned and funded by AstraZeneca.

    This is an AstraZeneca organised and funded non-promotional meeting facilitated by OHE.

OHE Academy

OHE Academy

OHE Events